Cargando…

Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors

To identify peptides with high affinity and specificity against human epidermal growth factor receptor 2 (HER2), a series of peptides were designed based on the structure of HER2 and its Z(HER2:342) affibody. By using a combination protocol of molecular dynamics modeling, MM/GBSA binding free energy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Lingling, Wang, Zihua, Yang, Xiaoliang, Li, Dan, Lian, Wenxi, Xiang, Zhichu, Wang, Weizhi, Bu, Xiangli, Lai, Wenjia, Hu, Zhiyuan, Fang, Qiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533098/ https://www.ncbi.nlm.nih.gov/pubmed/26284145 http://dx.doi.org/10.7150/thno.12398

Ejemplares similares

HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery
por: Geng, Lingling, et al.
Publicado: (2016)

Peptide probes derived from pertuzumab by molecular dynamics modeling for HER2 positive tumor imaging
por: Yang, Xiaoliang, et al.
Publicado: (2017)

Peptosome Coadministration Improves Nanoparticle Delivery to Tumors through NRP1-Mediated Co-Endocytosis
por: Xiang, Zhichu, et al.
Publicado: (2019)

A Protein Corona Adsorbed to a Bacterial Magnetosome Affects Its Cellular Uptake
por: Lai, Wenjia, et al.
Publicado: (2020)

A Novel Homodimer Peptide–Drug Conjugate Improves the Efficacy of HER2-Positive Breast Cancer Therapy
por: Liu, Shurong, et al.
Publicado: (2023)

Biocompatibility of Bacterial Magnetosomes as MRI Contrast Agent: A Long-Term In Vivo Follow-Up Study
por: Nan, Xiaohui, et al.
Publicado: (2021)

Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer’s Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2021)

Quantitative Liver-Specific Protein Fingerprint in Blood: A Signature for Hepatotoxicity
por: Hu, Zhiyuan, et al.
Publicado: (2014)

Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood
por: Guo, Yuxin, et al.
Publicado: (2022)

Bacterial Magnetosomes Release Iron Ions and Induce Regulation of Iron Homeostasis in Endothelial Cells
por: Lai, Wenjia, et al.
Publicado: (2022)

Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
por: You, Yiwen, et al.
Publicado: (2018)

Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp
por: Zhao, Minzhi, et al.
Publicado: (2015)

MMP-2-Controlled Transforming Micelles for Heterogeneic Targeting and Programmable Cancer Therapy
por: Wang, Zihua, et al.
Publicado: (2019)

Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases
por: Yang, Xiaojing, et al.
Publicado: (2023)

HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment
por: Wang, Mengting, et al.
Publicado: (2022)

Label-Free Quantitative Detection of Tumor-Derived Exosomes through Surface Plasmon Resonance Imaging
por: Zhu, Ling, et al.
Publicado: (2014)

Gold nanoparticles enhance antibody effect through direct cancer cell cytotoxicity by differential regulation of phagocytosis
por: Fan, Linyang, et al.
Publicado: (2021)

Nucleosome Positioning with Set of Key Positions and Nucleosome Affinity
por: Wang, Jia, et al.
Publicado: (2014)

Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells
por: Kucharczyk, Kamil, et al.
Publicado: (2020)

Branched Multimeric Peptides as Affinity Reagents for the Detection of α-Klotho Protein
por: Ye, Xiyun, et al.
Publicado: (2023)

Immunotherapy for HER-2 positive breast cancer
por: Yang, Tingting, et al.
Publicado: (2023)

Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain †
por: Cruz, Victor L., et al.
Publicado: (2023)

Peptide-Based Nanomaterials for Tumor Immunotherapy
por: Li, Lingyun, et al.
Publicado: (2020)

Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
por: Zhao, Dan, et al.
Publicado: (2019)

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
por: Ding, Yi, et al.
Publicado: (2018)

Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
por: Liu, Zhe, et al.
Publicado: (2012)

Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer
por: Zhang, Hang, et al.
Publicado: (2017)

Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib
por: Lian, Xiangyao, et al.
Publicado: (2020)

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
por: Ishimine, Yu, et al.
Publicado: (2015)

Clinical curative effect of neoadjuvant chemotherapy combined with immunotherapy and its impact on immunological function and the expression of ER, PR, HER-2 & SATB1 in HER-2-Positive breast cancer patients
por: Chen, Zhi, et al.
Publicado: (2022)

Threonine Phosphorylation of an Electrochemical Peptide-Based Sensor to Achieve Improved Uranyl Ion Binding Affinity
por: Thompson, Channing C., et al.
Publicado: (2022)

Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics
por: Cavallaro, Palmira Alessia, et al.
Publicado: (2023)

Oligomerization of Peptides LVEALYL and RGFFYT and Their Binding Affinity to Insulin
por: Chiang, Hsin-Lin, et al.
Publicado: (2013)

Hydrocarbon constrained peptides – understanding preorganisation and binding affinity
por: Miles, Jennifer A., et al.
Publicado: (2016)

Automated affinity selection for rapid discovery of peptide binders
por: Zhang, Genwei, et al.
Publicado: (2021)

Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification
por: Barredo-Vacchelli, Gabriela R., et al.
Publicado: (2021)

PPI-Affinity: A Web Tool for the Prediction and Optimization of Protein–Peptide and Protein–Protein Binding Affinity
por: Romero-Molina, Sandra, et al.
Publicado: (2022)

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients
por: Liu, Binliang, et al.
Publicado: (2022)

Systematic Modeling, Prediction, and Comparison of Domain–Peptide Affinities: Does it Work Effectively With the Peptide QSAR Methodology?
por: Liu, Qian, et al.
Publicado: (2022)

Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L
por: Geng, Jingping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ppg26r5n41mn8rd7lccgpj8cd